InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

Current share price for AFP : $3.500 0.05 (1.45%)+

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$367 FY2025 Distribution Notice correction 22 May 2025 12:16PM $2.450 $3.500 risen by 42.86%
$367 FY2025 Distribution notice 22 May 2025 7:31AM $2.550 $3.500 risen by 37.25%
$367 FY2025 Presentation 22 May 2025 7:30AM $2.550 $3.500 risen by 37.25%
$367 FY2025 Annual Report 22 May 2025 7:30AM $2.550 $3.500 risen by 37.25%
$367 FY2025 Market Release 22 May 2025 7:30AM $2.550 $3.500 risen by 37.25%
$367 FY2025 App2 22 May 2025 7:30AM $2.550 $3.500 risen by 37.25%
$367 AFTto announce full year results on Thursday May 22 2025 1 May 2025 7:30AM $2.340 $3.500 risen by 49.57%
$367 March investor update 31 Mar 2025 8:09AM $2.300 $3.500 risen by 52.17%
$367 ASX small cap presentation 250326 26 Mar 2025 7:51AM $2.300 $3.500 risen by 52.17%
$367 NEW YEAR LETTER TO INVESTORS 13 Jan 2025 7:30AM $2.550 $3.500 risen by 37.25%
$367 Disclosure of Directors and Senior Managers Relevant Interes 2 Dec 2024 12:50PM $2.720 $3.500 risen by 28.68%
$367 Disclosure of Directors and Senior Managers Relevant Interes 27 Nov 2024 2:41PM $2.470 $3.500 risen by 41.70%
$367 Disclosure of Directors and Senior Managers Relevant Interes 27 Nov 2024 2:40PM $2.470 $3.500 risen by 41.70%
$367 FY25 Interim Report 21 Nov 2024 7:32AM $2.150 $3.500 risen by 62.79%
$367 FY25 Interim Presentation 21 Nov 2024 7:32AM $2.150 $3.500 risen by 62.79%
$367 FY25 Interim release 21 Nov 2024 7:31AM $2.150 $3.500 risen by 62.79%
$367 FY25 Interim NZX App2 21 Nov 2024 7:31AM $2.150 $3.500 risen by 62.79%
$367 AFT appoints Allison Yorston as independent director 13 Nov 2024 7:30AM $2.570 $3.500 risen by 36.19%
$367 Change in substantial holding 7 Nov 2024 2:15PM $2.520 $3.500 risen by 38.89%
$367 AFT trading update 1 Nov 2024 7:30AM $2.880 $3.500 risen by 21.53%
$367 AFT enters late-stage R&D agreement for a novel injectable 21 Oct 2024 7:31AM $2.980 $3.500 risen by 17.45%
$367 Interim results to be announced on Nov 21 2024 11 Oct 2024 3:12PM $2.950 $3.500 risen by 18.64%
$367 China and USA updates 30 Sep 2024 5:35PM $3.030 $3.500 risen by 15.51%
$367 AFT adds COMBOGESIC Tablets to Hikma Agreement in US 8 Aug 2024 12:23PM $2.930 $3.500 risen by 19.45%
$367 2024 ASM results 2 Aug 2024 11:53AM $2.990 $3.500 risen by 17.06%

51 - 75 of 547 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.